Improving access to malaria medicine through private-sector subsidies in seven African countries

S Tougher, AG Mann, ACTwatch Group, Y Ye… - Health …, 2014 - healthaffairs.org
Improving access to quality-assured artemisinin combination therapies (ACTs) is an
important component of malaria control in low-and middle-income countries. In 2010 the …

Effect of the Affordable Medicines Facility—malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in …

S Tougher, Y Ye, JH Amuasi, IA Kourgueni, R Thomson… - The Lancet, 2012 - thelancet.com
Background Malaria is one of the greatest causes of mortality worldwide. Use of the most
effective treatments for malaria remains inadequate for those in need, and there is concern …

Do price subsidies on artemisinin combination therapy for malaria increase household use?: evidence from a repeated cross-sectional study in remote regions of …

JL Cohen, P Yadav, C Moucheraud, S Alphs… - PloS one, 2013 - journals.plos.org
Background The Affordable Medicines Facility-malaria (AMFm) is a pilot program that uses
price subsidies to increase access to Artemisinin Combination Therapies (ACTs), currently …

Two years post affordable medicines facility for malaria program: availability and prices of anti-malarial drugs in central Ghana

A Freeman, A Kwarteng, LG Febir… - … of pharmaceutical policy …, 2017 - Springer
Abstract Background The Affordable Medicines Facility for malaria (AMFm) Program was a
subsidy aimed at artemisinin-based combination therapies (ACTs) in order to increase …

Trends in availability and prices of subsidized ACT over the first year of the AMFm: evidence from remote regions of Tanzania

P Yadav, JL Cohen, S Alphs, J Arkedis, PS Larson… - Malaria Journal, 2012 - Springer
Abstract Background The Affordable Medicines Facility for malaria (AMFm) is a pilot supra-
national subsidy program that aims to increase access and affordability of artemisinin …

Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries

KA O'Connell, H Gatakaa, S Poyer, J Njogu, I Evance… - Malaria journal, 2011 - Springer
Background Artemisinin-based combination therapy (ACT) is the first-line malaria treatment
throughout most of the malaria-endemic world. Data on ACT availability, price and market …

Price subsidies increase the use of private sector ACTs: evidence from a systematic review

A Morris, A Ward, B Moonen, O Sabot… - Health Policy and …, 2015 - academic.oup.com
Background Although artemisinin combination therapies (ACTs) are the recommended first-
line treatment for uncomplicated malaria in most endemic countries, they have been …

[PDF][PDF] Distribution of artemisinin-based combination therapies through private-sector channels

O Sabot, S Yeung, F Pagnoni, M Gordon… - … DC: Resources For …, 2009 - media.rff.org
Substantial progress has been made in delivering ACTs through public health systems, but
high prices have kept ACTs from those buying antimalarials in pharmacies or shops—the …

Changes in the availability and affordability of subsidised artemisinin combination therapy in the private drug retail sector in rural Ghana: before and after the …

EK Ansah, CJM Whitty, C Bart-Plange… - International …, 2016 - academic.oup.com
Background Most people with febrile illness are treated in the private drug retail sector.
Ghana was among nine countries piloting the Global Fund Affordable Medicines Facility …

What happened to anti-malarial markets after the Affordable Medicines Facility-malaria pilot? Trends in ACT availability, price and market share from five African …

S Tougher, K Hanson, C Goodman - Malaria journal, 2017 - Springer
Background The private sector supplies anti-malarial treatment for large proportions of
patients in sub-Saharan Africa. Following the large-scale piloting of the Affordable …